Literature DB >> 16412055

Altered naive CD4 and CD8 T cell homeostasis in patients with relapsing-remitting multiple sclerosis: thymic versus peripheral (non-thymic) mechanisms.

D A Duszczyszyn1, J D Beck, J Antel, A Bar-Or, Y Lapierre, V Gadag, D G Haegert.   

Abstract

We have reported previously that naive T cells from relapsing-remitting multiple sclerosis (RRMS) patients have T cell receptor (TCR) repertoire shifts, but the basis of these TCR repertoire shifts was uncertain. Here, we questioned whether RRMS patients have altered naive CD4 and CD8 T cell homeostasis by studying homeostatic proliferation and thymic production in RRMS patients and healthy controls. We measured thymic production by quantifying signal joint T cell receptor excision circles (sjTRECs). Both naive T subsets from controls showed an age-associated decrease in sjTRECs, i.e. evidence of progressive thymic involution, but we detected no age-associated decrease in sjTRECs in RRMS patients. Instead, naive CD8 T cells from patients had lower sjTRECs (P = 0.012) and higher Ki-67 proliferation levels (P = 0.04) than controls. Naive CD4 T cell sjTRECs did not differ between patients and controls. However, in RRMS these sjTRECs correlated strongly with CD31, a marker expressed by newly generated CD4 T cells but not by naive CD4 T cells that have undergone homeostatic proliferation. HLA-DR2 positivity correlated negatively with naive CD4 T cell CD31 expression in RRMS (P = 0.002). We conclude in RRMS that naive T subsets have homeostatic abnormalities due probably to peripheral (non-thymic) mechanisms. These abnormalities could have relevance for MS pathogenesis, as naive T cell changes may precede MS onset.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16412055      PMCID: PMC1809592          DOI: 10.1111/j.1365-2249.2005.02990.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  38 in total

1.  Different contributions of thymopoiesis and homeostasis-driven proliferation to the reconstitution of naive and memory T cell compartments.

Authors:  Qing Ge; Hui Hu; Herman N Eisen; Jianzhu Chen
Journal:  Proc Natl Acad Sci U S A       Date:  2002-03-05       Impact factor: 11.205

2.  Naive T cells are maintained by thymic output in early ages but by proliferation without phenotypic change after age twenty.

Authors:  John M Murray; Gilbert R Kaufmann; Philip D Hodgkin; Sharon R Lewin; Anthony D Kelleher; Miles P Davenport; John J Zaunders
Journal:  Immunol Cell Biol       Date:  2003-12       Impact factor: 5.126

Review 3.  Maintaining the norm: T-cell homeostasis.

Authors:  Stephen C Jameson
Journal:  Nat Rev Immunol       Date:  2002-08       Impact factor: 53.106

4.  Reevaluation of T cell receptor excision circles as a measure of human recent thymic emigrants.

Authors:  Ping Ye; Denise E Kirschner
Journal:  J Immunol       Date:  2002-05-15       Impact factor: 5.422

5.  Oligoclonal expansion of memory CD8+ T cells in cerebrospinal fluid from multiple sclerosis patients.

Authors:  Marc Jacobsen; Sabine Cepok; Elfriede Quak; Michael Happel; Rami Gaber; Andreas Ziegler; Sabine Schock; Wolfgang H Oertel; Norbert Sommer; Bernhard Hemmer
Journal:  Brain       Date:  2002-03       Impact factor: 13.501

6.  Impaired thymic output and restricted T-cell repertoire in two infants with immunodeficiency and early-onset generalized dermatitis.

Authors:  S Pirovano; E Mazzolari; S Pasic; A Albertini; Luigi D Notarangelo; L Imberti
Journal:  Immunol Lett       Date:  2003-03-03       Impact factor: 3.685

7.  Evidence for adequate thymic function but impaired naive T-cell survival following allogeneic hematopoietic stem cell transplantation in the absence of chronic graft-versus-host disease.

Authors:  Jean-François Poulin; Myriam Sylvestre; Patrick Champagne; Marie-Lise Dion; Nadia Kettaf; Alain Dumont; Maryse Lainesse; Pierre Fontaine; Denis-Claude Roy; Claude Perreault; Rafick-Pierre Sékaly; Rémi Cheynier
Journal:  Blood       Date:  2003-08-21       Impact factor: 22.113

8.  Identical twins discordant for multiple sclerosis have a shift in their T-cell receptor repertoires.

Authors:  D G Haegert; D Galutira; T J Murray; P O'Connor; V Gadag
Journal:  Clin Exp Immunol       Date:  2003-12       Impact factor: 4.330

9.  Reversible disruption of thymic function by steroid treatment.

Authors:  Fan-Kun Kong; Chen-lo H Chen; Max D Cooper
Journal:  J Immunol       Date:  2002-06-15       Impact factor: 5.422

10.  Thymic export function and T cell homeostasis in patients with relapsing remitting multiple sclerosis.

Authors:  Andreas Hug; Mirjam Korporal; Isabella Schröder; Jürgen Haas; Katharina Glatz; Brigitte Storch-Hagenlocher; Brigitte Wildemann
Journal:  J Immunol       Date:  2003-07-01       Impact factor: 5.422

View more
  11 in total

1.  CNS-derived CCL21 is both sufficient to drive homeostatic CD4+ T cell proliferation and necessary for efficient CD4+ T cell migration into the CNS parenchyma following Toxoplasma gondii infection.

Authors:  Corinne C Ploix; Shahani Noor; Janelle Crane; Kokoechat Masek; Whitney Carter; David D Lo; Emma H Wilson; Monica J Carson
Journal:  Brain Behav Immun       Date:  2010-09-22       Impact factor: 7.217

2.  Rabbit antithymocyte globulin (thymoglobulin) impairs the thymic output of both conventional and regulatory CD4+ T cells after allogeneic hematopoietic stem cell transplantation in adult patients.

Authors:  Il-Kang Na; Friedrich Wittenbecher; Mikalai Dziubianau; Anne Herholz; Angela Mensen; Désirée Kunkel; Olga Blau; Igor Blau; Eckhard Thiel; Lutz Uharek; Carmen Scheibenbogen; Kathrin Rieger; Andreas Thiel
Journal:  Haematologica       Date:  2012-07-16       Impact factor: 9.941

3.  Compromised CD4+ CD25(high) regulatory T-cell function in patients with relapsing-remitting multiple sclerosis is correlated with a reduced frequency of FOXP3-positive cells and reduced FOXP3 expression at the single-cell level.

Authors:  Koen Venken; Niels Hellings; Marielle Thewissen; Veerle Somers; Karen Hensen; Jean-Luc Rummens; Robert Medaer; Raymond Hupperts; Piet Stinissen
Journal:  Immunology       Date:  2007-09-25       Impact factor: 7.397

4.  CCR5-delta 32 allele is associated with the risk of developing multiple sclerosis in the Iranian population.

Authors:  Majid Shahbazi; Hamid Ebadi; Davood Fathi; Danial Roshandel; Mana Mahamadhoseeni; Azam Rashidbaghan; Narges Mahammadi; Mahammad Reza Mahammadi; Mahdi Zamani
Journal:  Cell Mol Neurobiol       Date:  2009-12       Impact factor: 5.046

5.  Multiple sclerosis: a disorder of altered T-cell homeostasis.

Authors:  David G Haegert
Journal:  Mult Scler Int       Date:  2011-09-15

Review 6.  Self-tolerance in multiple sclerosis.

Authors:  R E Gonsette
Journal:  Acta Neurol Belg       Date:  2012-03-24       Impact factor: 2.396

7.  Naive CD4 T-cell activation identifies MS patients having rapid transition to progressive MS.

Authors:  Evelyn Zastepa; Leslie Fitz-Gerald; Michael Hallett; Jack Antel; Amit Bar-Or; Sergio Baranzini; Yves Lapierre; David G Haegert
Journal:  Neurology       Date:  2014-01-22       Impact factor: 9.910

8.  Memory B Cells Activate Brain-Homing, Autoreactive CD4+ T Cells in Multiple Sclerosis.

Authors:  Ivan Jelcic; Faiez Al Nimer; Jian Wang; Verena Lentsch; Raquel Planas; Ilijas Jelcic; Aleksandar Madjovski; Sabrina Ruhrmann; Wolfgang Faigle; Katrin Frauenknecht; Clemencia Pinilla; Radleigh Santos; Christian Hammer; Yaneth Ortiz; Lennart Opitz; Hans Grönlund; Gerhard Rogler; Onur Boyman; Richard Reynolds; Andreas Lutterotti; Mohsen Khademi; Tomas Olsson; Fredrik Piehl; Mireia Sospedra; Roland Martin
Journal:  Cell       Date:  2018-08-30       Impact factor: 41.582

9.  A new clustering method identifies multiple sclerosis-specific T-cell receptors.

Authors:  Fumie Hayashi; Noriko Isobe; Jacob Glanville; Takuya Matsushita; Guzailiayi Maimaitijiang; Shoko Fukumoto; Mitsuru Watanabe; Katsuhisa Masaki; Jun-Ichi Kira
Journal:  Ann Clin Transl Neurol       Date:  2021-01-05       Impact factor: 4.511

Review 10.  The contribution of thymic tolerance to central nervous system autoimmunity.

Authors:  Piero Alberti; Adam E Handel
Journal:  Semin Immunopathol       Date:  2020-10-27       Impact factor: 9.623

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.